🔴 Neuronetics is trading 5.2% down today following executive leadership changes and new CFO appointment

Neuronetics is trading 5.2% down at $1.92 after announcing significant executive leadership changes, including the appointment of a new CFO.

• Nir Naor has been named Executive Vice President, Chief Financial Officer, and Treasurer effective July 23, 2026, as part of a broader senior management transition.
• Citizens analysts reiterated a Market Outperform rating and $7.00 price target, citing confidence in the new leadership and recent strategic initiatives.
• The market reaction reflects investor digestion of the management reshuffle and its potential impact on the company's near-term operational execution.